Literature DB >> 12110613

Molecular modelling of the interactions of carbamazepine and a nicotinic receptor involved in the autosomal dominant nocturnal frontal lobe epilepsy.

M O Ortells1, G E Barrantes.   

Abstract

1. The normal and a mutant (S248F) human neuronal alpha4beta2 nicotinic receptors, and their interaction with the channel blocker carbamazepine (CBZ) have been modelled. The mutant, responsible for the autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), has an enhanced sensitivity to and a slower recovery from desensitization, a lower conductance, short open times, reduced calcium permeability, and is 3 fold more sensitive to CBZ, a drug used in the treatment of partial epilepsies. 2. Mutant channel properties are explained by the physicochemical properties of the two Phe248 side chains, including size and cation-pi interaction, and their dynamic behaviour. A defective mechanism of dehydration might be responsible for the reduced calcium influx. 3. Phe248 residues are the main component of CBZ binding sites in the mutant, while this is not true for Ser248 in the normal receptor. 4. A higher number of blocking binding sites and a predicted higher affinity found for CBZ in the mutant account for its differential sensitivity to CBZ. 5. Aromatic-aromatic interactions between CBZ and the two Phe248 account for the difference in affinity, which is at least 12 times higher for the mutant, depending on the method used for calculating K(i). 6. Normal vs mutant differences in K(i), enhanced by the higher number of blocking binding sites in the mutant, seem excessive compared to the differential sensitivities to CBZ experimentally found. The negative cooperativity suggested by a predicted overlapping of blocking and non-blocking binding sites gives an explanation, as overlapping is higher in the mutant. 7. For both types of receptors we found that the carbamyl group of the best blocking conformers of CBZ forms hydrogen bonds with serine residues, which may explain the fundamental role of that moiety for this molecule to act as antiepileptic drug. British Journal of Pharmacology (2002) 136, 883-895

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110613      PMCID: PMC1573415          DOI: 10.1038/sj.bjp.0704786

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors.

Authors:  H R Arias
Journal:  Neurosci Biobehav Rev       Date:  1999       Impact factor: 8.989

2.  Understanding channel blocking in the nicotinic acetylcholine receptor.

Authors:  M O Ortells; G E Barrantes
Journal:  Receptors Channels       Date:  2001

3.  A glia-derived acetylcholine-binding protein that modulates synaptic transmission.

Authors:  A B Smit; N I Syed; D Schaap; J van Minnen; J Klumperman; K S Kits; H Lodder; R C van der Schors; R van Elk; B Sorgedrager; K Brejc; T K Sixma; W P Geraerts
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Aromatic clusters: a determinant of thermal stability of thermophilic proteins.

Authors:  N Kannan; S Vishveshwara
Journal:  Protein Eng       Date:  2000-11

5.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

6.  A ring of uncharged polar amino acids as a component of channel constriction in the nicotinic acetylcholine receptor.

Authors:  K Imoto; T Konno; J Nakai; F Wang; M Mishina; S Numa
Journal:  FEBS Lett       Date:  1991-09-09       Impact factor: 4.124

7.  First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.

Authors:  S Baulac; G Huberfeld; I Gourfinkel-An; G Mitropoulou; A Beranger; J F Prud'homme; M Baulac; A Brice; R Bruzzone; E LeGuern
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

8.  Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine.

Authors:  F Picard; S Bertrand; O K Steinlein; D Bertrand
Journal:  Epilepsia       Date:  1999-09       Impact factor: 5.864

9.  Gas-phase reactions of hydrated alkaline earth metal ions, M2+ (H2O)n (M = Mg, Ca, Sr, Ba and n = 4-7), with benzene.

Authors:  S E Rodriguez-Cruz; E R Williams
Journal:  J Am Soc Mass Spectrom       Date:  2001-03       Impact factor: 3.109

10.  Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance.

Authors:  K Imoto; C Busch; B Sakmann; M Mishina; T Konno; J Nakai; H Bujo; Y Mori; K Fukuda; S Numa
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

View more
  2 in total

1.  Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response.

Authors:  Nivalda Rodrigues-Pinguet; Li Jia; Maureen Li; Antonio Figl; Alwin Klaassen; Anthony Truong; Henry A Lester; Bruce N Cohen
Journal:  J Physiol       Date:  2003-05-16       Impact factor: 5.182

2.  Nocturnal Frontal Lobe Epilepsy vs Parasomnias.

Authors:  Christopher Derry
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.